These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


419 related items for PubMed ID: 11030486

  • 21. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 22. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 23. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Aug; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 24. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M.
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [Abstract] [Full Text] [Related]

  • 25. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
    Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.
    J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
    [Abstract] [Full Text] [Related]

  • 26. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
    Høyberg OJ, Maragakis B, Mullin J, Norum D, Stordall E, Ekdahl P, Ose E, Moksnes KM, Sennef C.
    Acta Psychiatr Scand; 1996 Mar; 93(3):184-90. PubMed ID: 8739664
    [Abstract] [Full Text] [Related]

  • 27. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
    Romeo R, Patel A, Knapp M, Thomas C.
    Int Clin Psychopharmacol; 2004 May; 19(3):125-34. PubMed ID: 15107654
    [Abstract] [Full Text] [Related]

  • 28. A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression.
    Marttila M, Jääskeläinen J, Järvi R, Romanov M, Miettinen E, Sorri P, Ahlfors U, Zivkov M.
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):441-6. PubMed ID: 8998395
    [Abstract] [Full Text] [Related]

  • 29. Does mirtazapine have a more rapid onset than SSRIs?
    Quitkin FM, Taylor BP, Kremer C.
    J Clin Psychiatry; 2001 May; 62(5):358-61. PubMed ID: 11411818
    [Abstract] [Full Text] [Related]

  • 30. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 31. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
    Haapasalo-Pesu KM, Vuola T, Lahelma L, Marttunen M.
    J Child Adolesc Psychopharmacol; 2004 Apr; 14(2):175-84. PubMed ID: 15319015
    [Abstract] [Full Text] [Related]

  • 32. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A, Feiger A.
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [Abstract] [Full Text] [Related]

  • 33. Care of depressed patients with anxiety symptoms.
    Nutt DJ.
    J Clin Psychiatry; 1999 Apr; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [Abstract] [Full Text] [Related]

  • 34. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.
    Ballús C, Quiros G, De Flores T, de la Torre J, Palao D, Rojo L, Gutiérrez M, Casais L, Riesgo Y.
    Int Clin Psychopharmacol; 2000 Jan; 15(1):43-8. PubMed ID: 10836286
    [Abstract] [Full Text] [Related]

  • 35. Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss.
    Jiang SM, Jia L, Liu J, Shi MM, Xu MZ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5260-6. PubMed ID: 27298569
    [Abstract] [Full Text] [Related]

  • 36. Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.
    Kasper S.
    Int Clin Psychopharmacol; 1995 Dec 14; 10 Suppl 4():25-35. PubMed ID: 8930007
    [Abstract] [Full Text] [Related]

  • 37. Mirtazapine in major depression with comorbid generalized anxiety disorder.
    Goodnick PJ, Puig A, DeVane CL, Freund BV.
    J Clin Psychiatry; 1999 Jul 14; 60(7):446-8. PubMed ID: 10453798
    [Abstract] [Full Text] [Related]

  • 38. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH.
    J Clin Psychiatry; 1997 Mar 14; 58(3):112-8. PubMed ID: 9108813
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
    Waintraub L, Septien L, Azoulay P.
    CNS Drugs; 2002 Mar 14; 16(1):65-75. PubMed ID: 11772119
    [Abstract] [Full Text] [Related]

  • 40. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.
    Am J Psychiatry; 2006 Sep 14; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.